2023 - Associate Director AstraZeneca Employee Review

3.0
Nov 23, 2023
Recommend
CEO approval
Business Outlook

Pros

Enormous growth potential especially in the oncology department

Cons

Unable to deal with the growth, lacking infrastructure, very competitive enviornment

Explore other reviews about AstraZeneca

5.0
Jun 25, 2026
Recommend
CEO approval
Business Outlook

Pros

Good products, great oncology pipeline

Cons

Global leaders moving to US that have limited understanding of US environment

4.0
Jun 29, 2026
Recommend
CEO approval
Business Outlook

Pros

Lots to learn with multiple launches and focus on AI

Cons

heavy middle layer slows down decision making

See reviews by: Helpful|Rating|Date|All